tirzepatide approval date health canada zepbound obesity canada 💉 GLP-1 Injectable Options in 🇨🇦 health canada approval zepbound tirzepatide

Fridays primarily offers compounded GLP-1 medications, which are produced in FDA-registered facilities but have not been evaluated by the FDA for safety, efficacy or quality

Dizziness has been reported in clinical studies, affecting approximately 6-8% of patients receiving Wegovy and 4% of patients receiving Ozempic

This approach can help maximize the antioxidant benefits and improve the overall effectiveness of supplementation

Certain symptoms warrant prompt medical attention

In contrast, recent meta-analyses suggest that GLP-1 RA use does not increase the risk of pancreatitis and/or pancreatic cancer, compared to placebo and/or other treatments [101,102,103]